Abstract:Resveratrol (Res), a potent nutraceutical, holds promise in ameliorating cancer and catalyzing breakthroughs in cancer therapy. Despite numerous preclinical studies on its anticancer activity, translational research progress remains limited. Poor pharmacokinetics and low potency are primary bottlenecks of Res therapy. In this study, we aimed to enhance the pharmacokinetic profile of Res in a rat model and assess its cytotoxicity against human ovarian cancer cells by developing Res loaded Nanostructured Lipid Carriers (Res-NLCs). The Res-NLCs were synthesized using the solvent injection method, featuring a size of 177 nm, a PDI of 0.25, and an entrapment efficiency exceeding 80%. The formulation exhibited stability for three months at 4 °C and 40 °C. Cytotoxicity assessments using the MTT assay and cellular uptake studies on human ovarian cancer cells (PA1 and SKOV3 luc) revealed significantly superior time-dependent cytotoxic effects and cellular accumulation of Res-NLCs compared to free Res. Pharmacokinetic studies of intravenously administered Res in NLCs demonstrated prolonged plasma levels of Res for at least 48 h. Remarkably, Res-NLCs exhibited approximately 15- and 5-fold improvements in AUC and elimination half-life (t 1/2 ), respectively, compared to Res in solution in rats. Moreover, Res tissue distribution from Res-NLCs in rats showed significantly higher accumulation in the liver, lungs, and ovaries over 48 h, underscoring the potential for targeted therapy. In conclusion, NLCs effectively mitigated premature reduction of Res in the bloodstream, prolonged circulation period, and enhanced tissue accumulation. These findings suggest promising prospects for improving therapeutic outcomes in ovarian cancer therapy using Res-NLCs.

Carrier-Free, Pure Resveratrol Micro-/Nanoribbon: Simple Preparation and Enhanced Bioactivity

Recent progress in nanotechnology-based drug carriers for resveratrol delivery

Mesoporous Silica Nanoparticles Loaded with Resveratrol Are Used for Targeted Breast Cancer Therapy

Evaluation of Free Radical Scavenging Capacity and Antioxidative Damage Effect of Resveratrol-Nanostructured Lipid Carriers

Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer

Preparation and in Vitro/in Vivo Evaluation of Resveratrol-Loaded Carboxymethyl Chitosan Nanoparticles

Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers

Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels.

Anti-Hepatocarcinoma Effects of Resveratrol Loaded Solid Nanodispersion by A New Material Nano Silica

Preparation of Hyaluronic Acid-Coated Resveratrol Nanomicelles and Its In Vitro Evaluation

Nanostructured Lipid Carriers Enhance the Bioavailability and Brain Cancer Inhibitory Efficacy of Curcumin Both in Vitro and in Vivo

Preparation and Biological Activity Studies of Resveratrol Loaded Ionically Cross-Linked Chitosan-Tpp Nanoparticles.

Resveratrol Nanoparticles Coated by Metal-Polyphenols Supramolecular Enhance Antioxidant Activity and Long-Term Stability of Dietary Gel

Enhancing resveratrol pharmacokinetics and cytotoxicity in ovarian cancer cells via nanostructured lipid carriers

Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells

Recent advances in nanodelivery systems of resveratrol and their biomedical and food applications: a review

A Resveratrol-Loaded Nanostructured Lipid Carrier Hydrogel to Enhance the Anti-Uv Irradiation and Anti-Oxidant Efficacy

Characterizations and Bioavailability of Dendrimer-like Glucan Nanoparticulate System Containing Resveratrol

Application of Liposome Encapsulation Technique to Improve Anti-Carcinoma Effect of Resveratrol.

Enhancement of biological activities of nanostructured hydrophobic drug species.

Anti-breast cancer activity of resveratrol encapsulated in liposomes